Clinical Trials Logo

Clinical Trial Summary

Influenza continues to inflict an important burden on health-care systems. The 2009 H1N1 influenza virus first appeared in Mexico and the United States in March and April 2009 and has swept the globe with unprecedented speed.

The aim of this study is to evaluate effect of supplement vitamin on the clinical course of patients with acute respiratory illness suspected novel H1N1 infection.


Clinical Trial Description

Patients with acute respiratory illness randomized to control or vitamin groups. The patients completed questionnaire about their initial symptom scores. After 5 days of vitamin trial, patients were asked about their symptom by telephone survey. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01127282
Study type Interventional
Source Seoul National University Hospital
Contact Chang-Hoon Lee, MD
Phone +82- 2- 870- 2232
Email kauri670@gmail.com
Status Unknown status
Phase Phase 4
Start date December 2009
Completion date August 2010

See also
  Status Clinical Trial Phase
Completed NCT03641690 - Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome
Terminated NCT00970606 - STIP: Statin Trial for Influenza Patients N/A
Completed NCT02921997 - H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses Phase 2
Recruiting NCT01008683 - Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation N/A
Completed NCT01011582 - Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza N/A
Active, not recruiting NCT01421251 - H1N1 Vaccine Safety in Manitoba, Canada N/A
Recruiting NCT04497311 - Tomographic Findings in COVID-19 and Influenza
Completed NCT04933994 - Comparison of COVID-19 and H1N1 Influenza Pneumonia
Completed NCT01002040 - Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV Phase 4
Terminated NCT01798602 - Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial Phase 2
Terminated NCT04810949 - Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml N/A
Completed NCT05080933 - ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS